• Member News

Coulter Partners opens Brussels office and makes six strategic appointments

Global Life Sciences search specialist, Coulter Partners is delighted to announce the opening of a new office in the Belgian capital and six key appointments. Penny Sadler strengthens the company’s rapidly growing Medtech expertise as Client Partner in Brussels, while Dr Nanna Soni (PhD DIC) is appointed Director in London to the R&D centre of expertise. Please see Press Release for full details.

Mogrify wins Seed Stage Finance Raise of the Year at 2019 European Lifestars Awards

Mogrify Ltd is pleased to announce that is has been recognized as the winner of the Seed Stage Finance Raise of the Year award at the 2019 Lifestars Awards.

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).

£1.2m investment to reinforce Stevenage Campus as world class cell and gene therapy hub

Hertfordshire Local Enterprise Partnership is to invest £1.2m into Stevenage Bioscience Catalyst (SBC) to help grow a world-class cell and gene therapy cluster. The £1.2m Local Growth Fund investment will provide much-needed temporary accommodation for growing cell and gene therapy companies, strengthening the UK’s sectorial advantage and Hertfordshire’s position within the Oxford-London-Cambridge golden research triangle.

Arecor to present at the Sixth China Healthcare Summit 2019 in Shanghai, China

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that its Chief Executive Officer, Dr Sarah Howell, will present at The sixth China Healthcare Summit, held from 18th to 20th November at the Jing An Shangri-La, Shanghai, China.

Taking Newcastle to the world at BioJapan 2019

Senior Investment Manager Matt Bratton reflects on his time in Japan and the thriving life sciences sector in the North East of England.

Horizon Discovery divests animal models business to Envigo

• Animal model operations to be transferred to Envigo ownership • Divestment in line with Horizon’s corporate strategy to focus on its core markets • Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business • Horizon and Envigo to collaborate on providing CRISPR screening services

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies

Cognate BioServices announces acquisition of Cobra Biologics

- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction

Repositive unveils molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery

Repositive is unveiling molecular search functionality for its Cancer Models Platform today at ELRIG Drug Discovery. The first version of this innovative feature enables pharma and biotech scientists to search Repositive’s cancer model directory by their gene of interest and explore different mutations available to ensure they source a cancer model with the right molecular profile for their preclinical study.